Kamada (KMDA) Other Non-Current Assets (2012 - 2025)
Kamada's (KMDA) quarterly Other Non-Current Assets came in at $1.4 million in Q4 2025, up 1163.39% YoY from $112000.0 in Q4 2024, and up 1163.39% on a QoQ basis from $112000.0 in Q4 2024.
Kamada (KMDA) Other Non-Current Assets (2012 - 2025) Analysis & Trends
Kamada (KMDA) has 14 years of Other Non-Current Assets data on file, last reported at $1.4 million in Q4 2025.
- Quarterly Other Non-Current Assets rose 1163.39% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 1163.39% YoY) and the FY2025 annual result came in at $1.4 million, up 1163.39% from the prior year.
- Other Non-Current Assets grew to $1.4 million in Q4 2025, from $112000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $153.7 million in Q4 2021 to a low of $112000.0 in Q4 2024.
- A 5-year average of $70.3 million and a median of $7.6 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets surged 9668.79% — and 2022, when it slumped 95.07%.
- Tracing KMDA's Other Non-Current Assets over 5 years: stood at $153.7 million in 2021, then tumbled by 95.07% to $7.6 million in 2022, then tumbled by 93.27% to $510000.0 in 2023, then tumbled by 78.04% to $112000.0 in 2024, then surged by 1163.39% to $1.4 million in 2025.
- The last three Other Non-Current Assets figures came in at $1.4 million (Q4 2025), $112000.0 (Q4 2024), and $510000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Kamada | 463.48 Mn | 434.00 Mn | 22.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 510,000.00 |
| Jun 30, 2023 | 143.99 Mn |
| Mar 31, 2023 | 145.31 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 148.62 Mn |
| Jun 30, 2022 | 150.45 Mn |
| Mar 31, 2022 | 151.86 Mn |
| Dec 31, 2021 | 153.66 Mn |
| Sep 30, 2021 | 3.38 Mn |
| Jun 30, 2021 | 3.41 Mn |
| Mar 31, 2021 | 3.18 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.05 Mn |
| Dec 31, 2019 | 352,000.00 |
| Sep 30, 2019 | 178,000.00 |
| Jun 30, 2019 | 174,000.00 |